With the new service, Resolve said researchers in North America and Europe will be able to submit samples of interest for analysis and get data back from Resolve's technical team. Molecular Cartography consists of multiplexed, single-molecule detection technology that measures transcriptomic activity with full spatial context at subcellular resolution.

In other news, the company announced it has expanded its global footprint, opening a new facility in San Jose, CA. Furthermore, Resolve named Chris Barbazette as its CEO. Prior to this appointment, Barbazette held senior commercial positions at GenapSys, Agendia, and Affymetrix.

Resolve platform provides insights into disease, development
Resolve Biosciences has established collaborations in Europe to use its Molecular Cartography subcellular spatial analysis technology to address challenges...